题名 | How to treat CML patients in the tyrosine kinase inhibitors era? From imatinib standard dose to second generation drugs front-line: unmet needs, pitfalls and advantages |
作者 | Breccia M, Alimena G |
杂志 | Cancer Lett. |
年|卷|期 | 2012 Sep 28;322(2):127-32. |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/22450750 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |